Recent strides in non‐invasive drug delivery have spurred innovation in alternatives to traditional needle injections. Transdermal drug delivery systems (TDDs) have emerged as a particularly promising avenue, boasting minimal rejection rates, user‐friendly administration, and enhanced patient adherence. Beyond pharmaceuticals, TDDs show potential in skincare and cosmetics, leveraging their ability to facilitate localized drug delivery while minimizing systemic exposure. Nonetheless, the intricate physicochemical nature of the skin presents formidable obstacles, prompting intensive exploration to overcome these barriers. This comprehensive review delves into the landscape of TDDs methodologies, critically analyzing their respective advantages, limitations, characterization methodologies, and prospective applications. Recent advancements underscore the robust efficacy of TDDs, positioning it as a versatile and indispensable modality poised for widespread integration across multifarious fields.
This review highlights silk fibroin's potential in bone tissue engineering, exploring its properties, extraction methods, and applications in various forms, while addressing its challenges and future prospects.
Progesterone (PG) deficiency is a leading cause of impaired pregnancy maintenance, while current therapies such as frequent intramuscular injections suffer from poor compliance, inconvenience, and clinical risks. To address these issues, we report a self-heating microneedle (MN) patch designed for comfortable, sustained, and efficient thermally enhanced transdermal delivery of PG. The integrated system incorporates PG-loaded MNs, a 3D-printed backing layer with trigger mechanism, and a quicklime/activated charcoal (CaO + C) exothermic mixture that enables controllable and efficient self-heating effects (>60 °C). In vitro and in vivo drug release studies demonstrate that efficient and sustained thermal conduction facilitates polymer dissolution, accelerates drug release and diffusion (by > 70%), enhances skin permeability, and improves local blood flow, supporting systemic circulation. In a pregnant rat model, a single patch application maintained therapeutic PG levels for over 10 h and was associated with improved neonatal survival and reduced preterm birth. This self-administered patch, with proven biosafety and no need for external devices, presents a convenient, compliant, low-cost, and highly efficient strategy for PG supplementation, and warrants further investigation in pregnancy maintenance.